H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: NVCR) | Delayed: 13.36 +0.15 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.21 | 52 Week High | $28.95 | |||
| Open | $13.30 | 52 Week Low | $5.95 | |||
| Day High | $13.56 | P/E | N/A | |||
| Day Low | $13.21 | EPS | $0.00 | |||
| Volume | 599,329 | |||||
